Associate Professor Mark Arnold

Head of Clinical School
Medicine, School of Rural Health (Dubbo/Orange)

Telephone +61 2 5809 9400
Fax +61 2 5809 9498

Website School of Rural Health (Dibbo/Orange)

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Arnold, M., Finniss, D., Kerridge, I. (2018). 'But What Do You Mean, Doctor?' War Metaphors, Chronic Health Impacts, and Pain Threshold: The Physician as a Talking Placebo or Nocebo. AJOB Neuroscience, 9(3), 204-206. [More Information]
  • Rogenmoser, S., Arnold, M. (2018). Chronic gout: Barriers to effective management. Australian Journal of General Practice, 47(6), 351-356.
  • Morrisroe, K., Nakayama, A., Soon, J., Arnold, M., Barnsley, L., Barrett, C., Brooks, P., Hall, S., Hanrahan, P., Hissaria, P., et al (2018). EVOLVE: The Australian Rheumatology Association's 'top five' list of investigations and interventions doctors and patients should question. Internal Medicine Journal, 48(2), 135-143. [More Information]
  • Arnold, M., Kerridge, I. (2018). Rejecting Reality and Substituting One's Own; Why Bioethics Should Be Concerned With Medically Unexplained Symptoms. The American Journal of Bioethics, 18(5), 26-28. [More Information]
  • Arnold, M., Smith-Merry, J., Lane, A. (2018). The efficacy of medical student selection tools in Australia and New Zealand. Medical Journal of Australia, 209(4), 188. [More Information]
  • Arnold, M., Bleasel, J., Haq, I. (2016). Nocebo effects in practice: Methotrexate myths and misconceptions. Medical Journal of Australia, 205(10), 2. [More Information]
  • Arnold, M., Kerridge, I., Komesaroff, P. (2016). Watching the Responsibility Clock: Medical Care, Ethics, and Medical Shift Work. The American Journal of Bioethics, 16(9), 22-24. [More Information]
  • Arnold, M., Finniss, D., Kerridge, I. (2015). Destigmatising the Placebo Effect. The American Journal of Bioethics, 15(10), 21-23. [More Information]
  • Arnold, M. (2015). Determinants of rural practice: positive interaction between rural background and rural undergraduate training. Medical Journal of Australia, 202(9), 477-477. [More Information]
  • Tymms, K., Zochling, J., Scott, J., Bird, P., Burnet, S., De Jager, J., Griffiths, H., Nicholls, D., Roberts, L., Arnold, M., et al (2014). Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity. Arthritis Care and Research, 66(2), 190-196. [More Information]
  • Tan, A., Parker, N., Arnold, M. (2014). Candida glabrata vertebral osteomyelitis in an immunosuppressed patient. International Journal of Rheumatic Diseases, 17(2), 229-231. [More Information]
  • Arnold, M., Finniss, D., Kerridge, I. (2014). Medicine's inconvenient truth: the placebo and nocebo effect. Internal Medicine Journal, 44(4), 398-405. [More Information]
  • Littlejohn, G., Roberts, L., Arnold, M., Bird, P., Burnet, S., De Jager, J., Griffiths, H., Nicholls, D., Scott, J., Zochling, J., et al (2013). A multi-center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control. International Journal of Rheumatic Diseases, 16(5), 532-538. [More Information]
  • Finniss, A., Arnold, M. (2013). Soft tissue rheumatic disorders. Part 1. Aetiology and diagnosis. Medicine Today, 14(1), 49-51.
  • Finniss, A., Arnold, M. (2013). Soft tissue rheumatic disorders: Part 2. Treatment. Medicine Today, 2(2), 61-64.
  • Bird, P., Griffiths, H., Tymms, K., Nicholls, D., Roberts, L., Arnold, M., Burnet, S., de Jager, J., Scott, J., Zochling, J., et al (2013). The SMILE study-safety of methotrexate in combination with leflunomide in rheumatoid arthritis. Journal of Rheumatology, 40(3), 228-235. [More Information]
  • Arnold, M. (2011). Rheumatic disease research and implications for clinical care, a comment. International Journal of Clinical Practice, 65(9), 1015-1016. [More Information]
  • Milne, B., Arnold, M., Hudson, B., Coolican, M. (2009). Infectious arthritis of the knee caused by Mycobacterium terrae: a case report. Journal of Orthopaedic Surgery, 17(1), 103-108. [More Information]

2018

  • Arnold, M., Finniss, D., Kerridge, I. (2018). 'But What Do You Mean, Doctor?' War Metaphors, Chronic Health Impacts, and Pain Threshold: The Physician as a Talking Placebo or Nocebo. AJOB Neuroscience, 9(3), 204-206. [More Information]
  • Rogenmoser, S., Arnold, M. (2018). Chronic gout: Barriers to effective management. Australian Journal of General Practice, 47(6), 351-356.
  • Morrisroe, K., Nakayama, A., Soon, J., Arnold, M., Barnsley, L., Barrett, C., Brooks, P., Hall, S., Hanrahan, P., Hissaria, P., et al (2018). EVOLVE: The Australian Rheumatology Association's 'top five' list of investigations and interventions doctors and patients should question. Internal Medicine Journal, 48(2), 135-143. [More Information]
  • Arnold, M., Kerridge, I. (2018). Rejecting Reality and Substituting One's Own; Why Bioethics Should Be Concerned With Medically Unexplained Symptoms. The American Journal of Bioethics, 18(5), 26-28. [More Information]
  • Arnold, M., Smith-Merry, J., Lane, A. (2018). The efficacy of medical student selection tools in Australia and New Zealand. Medical Journal of Australia, 209(4), 188. [More Information]

2016

  • Arnold, M., Bleasel, J., Haq, I. (2016). Nocebo effects in practice: Methotrexate myths and misconceptions. Medical Journal of Australia, 205(10), 2. [More Information]
  • Arnold, M., Kerridge, I., Komesaroff, P. (2016). Watching the Responsibility Clock: Medical Care, Ethics, and Medical Shift Work. The American Journal of Bioethics, 16(9), 22-24. [More Information]

2015

  • Arnold, M., Finniss, D., Kerridge, I. (2015). Destigmatising the Placebo Effect. The American Journal of Bioethics, 15(10), 21-23. [More Information]
  • Arnold, M. (2015). Determinants of rural practice: positive interaction between rural background and rural undergraduate training. Medical Journal of Australia, 202(9), 477-477. [More Information]

2014

  • Tymms, K., Zochling, J., Scott, J., Bird, P., Burnet, S., De Jager, J., Griffiths, H., Nicholls, D., Roberts, L., Arnold, M., et al (2014). Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity. Arthritis Care and Research, 66(2), 190-196. [More Information]
  • Tan, A., Parker, N., Arnold, M. (2014). Candida glabrata vertebral osteomyelitis in an immunosuppressed patient. International Journal of Rheumatic Diseases, 17(2), 229-231. [More Information]
  • Arnold, M., Finniss, D., Kerridge, I. (2014). Medicine's inconvenient truth: the placebo and nocebo effect. Internal Medicine Journal, 44(4), 398-405. [More Information]

2013

  • Littlejohn, G., Roberts, L., Arnold, M., Bird, P., Burnet, S., De Jager, J., Griffiths, H., Nicholls, D., Scott, J., Zochling, J., et al (2013). A multi-center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control. International Journal of Rheumatic Diseases, 16(5), 532-538. [More Information]
  • Finniss, A., Arnold, M. (2013). Soft tissue rheumatic disorders. Part 1. Aetiology and diagnosis. Medicine Today, 14(1), 49-51.
  • Finniss, A., Arnold, M. (2013). Soft tissue rheumatic disorders: Part 2. Treatment. Medicine Today, 2(2), 61-64.
  • Bird, P., Griffiths, H., Tymms, K., Nicholls, D., Roberts, L., Arnold, M., Burnet, S., de Jager, J., Scott, J., Zochling, J., et al (2013). The SMILE study-safety of methotrexate in combination with leflunomide in rheumatoid arthritis. Journal of Rheumatology, 40(3), 228-235. [More Information]

2011

  • Arnold, M. (2011). Rheumatic disease research and implications for clinical care, a comment. International Journal of Clinical Practice, 65(9), 1015-1016. [More Information]

2009

  • Milne, B., Arnold, M., Hudson, B., Coolican, M. (2009). Infectious arthritis of the knee caused by Mycobacterium terrae: a case report. Journal of Orthopaedic Surgery, 17(1), 103-108. [More Information]

To update your profile click here. For support on your academic profile contact .